THE DEVELOPMENT and growth of syngeneic tumours is influenced in many cases by the cell-mediated immunoreactivity of the host organism. However, the direction taken by such influence is not always one way.
Although cellular-mediated resistance to tumour development in vivo and cellmediated lysis of neoplastic cells in vitro are general findings in several human and experimental host-tumour systems (for a review see Hellstrom and Hellstrom, 1974) there are several other situations in which cellular-mediated enhancement of tumour cell growth appears to take place both in vitro (Prehn, 1972; Klein, 1972; Fidler, 1973; Fidler, Brodey and BechNielsen, 1974; Kall and Hellstrom, 1975; Nathan and Terry, 1975) and in vivo (Belayev and Gruntenko, 1972; Fidler, 1974; Carnaud et al., 1974; Umiel and Trainin, 1974) . These contrasting findings can be interpreted by the theory, advanced by Prehn, that the effect of immunity might be biphasic, that is, a mild incipient immune response may be stimulatory to tumour growth but a strong one can be inhibitory (Prehn and Lappe, 1971) .
In an earlier paper, we showed that newborn mice appear to have less spontaneous resistance than adults, to the growth of transplantable tumours. The minimum number of neoplastic cells necessary for the induction of the same percentage of tumours increased in a parallel way with the post-natal development of the immunocapability of the recipient. The immunological nature of the resistance shown by untreated adult mice is supported by the fact that the resistance to tumour growth shown by heavily irradiated adult mice is identical to that observed in neonatal mice. Thus the lower resistance of the neonatal animal seemed to be directly dependent on its weaker immunological capability ).
The present study shows that the transfer into newborn mice of different numbers and types of leucocytes from normal adult mice influences in different ways the growth of a transplantable syngeneic chemically induced plas-macytoma. Inhibition or enhancement of tumour growth appears to be dependent on the type and dose of cells transferred.
MATERIALS AND METHODS
Mice.-Brother-sister mated, inbred Balb/c mice were used. This strain originated from the colony bred in the Animal Production Branch of the National Institute of Health (Bethesda, Md., U.S.A.). The various groups of 20 newborn mice 8 to 12 h old were randomly fostered from different littermates.
Tumour.-An IgA plasmacytoma, MOPC-460, chemically induced in the NIH Balb/c strain, was used (Potter, 1967) . The tumour was transmitted to the newborn mice by s.c. inoculations in the neck region of 3 x 104 live cells, obtained by mechanical teasing, in 0-1 ml volume. Cell viability was determined by the trypan blue dye exclusion test as described by Takahashi, Old and Boyse (1970) . Mice were periodically examined for a period of 80 days to determine the day of tumour appearance. In all animal groups, however, the percentage tumour take did not change after the first 20 days. (Kall and Hellstrom, 1975) . Peritoneal macrophages were obtained by washing the peritoneal cavity 72 h after inoculation of the above broth and by incubating the cell suspension in plastic Petri dishes (Falcon Plastic, Los Angeles) for 4 h at 37°C in 95% air and 5% CO2. Non-adherent cells were then washed out and the adherent cells, containing more than 95% macrophages capable of ingesting latex particles (Greineder and Rosenthal, 1975) were removed from the Petri dishes with a rubber policeman. All the cell suspensions were allowed to stand for 3 min at 4°C to permit settling of debris.
The supernatants, containing cells in suspension, were centrifuged twice at 400 g for 7 min at 4°C. The pellets were then suspended in suitable concentrations in HBSS without serum. All cell counts reported refer to the viable cells as judged by the exclusion of trypan blue. Only preparations containing more than 85% viable cells were used. The control preparations, containing 100% dead cells, were obtained by freezing and thawing the various cell suspensions 4 times.
Statistical analysis.-The variation in tumour take in every single experiment was evaluated by using chi-squared analysis with Yates' correction for small sample size.
RESULTS
Various groups of 20 8-to 12-h-old animals were injected i.p. with 0-1 ml of cell suspensions containing numbers of cells ranging from 5 x 103 to 1 x 108 of the various kinds of leucocytes obtained from normal adult donors. Twenty-fourh later all the newborn animal groups were challenged s.c. with 3 x 104 living MOPC-460 cells. This number of cells induces about 50% of tumour take in newborn animals and in heavily irradiated adult mice, as determined in preliminary experiments. On the other hand, when the same dose was injected into untreated adult animals older than 6 weeks, tumour induction of only 10% was observed. Progressive tumour growth and no regression was observed in all newborn and adult animals in whom an initial pinpoint tumour was detected. However, these tumours appear earlier and grow faster in newborn and adult lethally irradiated mice than in untreated adult mice .
As can be seen in the This enhancing effect on tumour growth was however reversed when higher doses of neutrophils and thymus cells had been inoculated previously. When cell numbers higher than 5 x 106 of these cell types were injected, a considerable protection against tumour development was observed. The protection given to newborn mice by high doses of thymocytes, bone marrow cells, neutrophils and macrophages resulted in a frequency of tumour take similar to that observed in untreated adult animals. In contrast, no substantial modification of tumour incidence was obtained when higher numbers of spleen cells were transferred.
Twenty-five control groups were simultaneouslypreinoculatedin a similar manner with logarithmic dilutions (from 5 x 103 to 5 X 107) of the different kinds of leucocytes killed by freezing and thawing. This transfer of different numbers of killed cells failed to influence the percentage of tumour take by more than ± 5%.
The experiment was repeated 3 times and consistent increases and decreases in percentage of tumour take were observed in the various groups.
DISCUSSION
The findings obtained indicate that, in the host-tumour model used, the transfer of different doses of syngeneic leucocytes from normal adult mice to newborn mice can lead to -a biphasic modification of final tumour incidence in the recipients. In effect, both a block and enhancement of tumour growth can be induced by adoptive transfer of difference amounts of the same cell population.
The tumour used in this study presents tumour-specific and tumour-associated antigens (Lynch et al., 1972; Comoglio and Forni, 1973) which can be employed to induce resistance in syngeneic animals. Previous work also indicated that the take and growth of this tumour is influenced LU e by spontaneous or artificially induced changes in host immune reactivity . These data suggest that MOPC-460 growth in syngeneic animals is hindered by a spontaneously induced mechanism of an immunological type. In effect, the resistance to MOPC-460 growth appears to increase in a parallel way with the course of immunological reactivity during postnatal development.
In this host-tumour system the resistance adoptively transferred to the newborn mice by sufficient numbers of macrophages, neutrophils, thymus and bone marrow cells from normal adult donors is comparable with the spontaneous resistance displayed by the adult mice challenged with the same number of tumour cells. The fact that cytotoxic activity against syngeneic tumour cells can be observed with a variety of different cells, such as macrophages (Evans and Alexander, 1972) , T lymphocytes (Rollinghoff and Wagner, 1973), B lymphocytes (Lamon et al., 1973) and neutrophils (Pickaver et al., 1972 ) is well established.
The marked blocking of tumour take observed in this study by the adoptive transfer in the newborn mice of high doses of these cell populations from adult mice suggests that the inability of untreated newborns to reject tumours is related to a lower number of these leucocyte types and/or a decreased functional capability of these cells in neonatal mice as compared the adult mice.
Macrophages produce a constant reduction of tumour take over a range of of 5 X 104 to 1 X 106 cells. It seems feasible that the role of macrophages (and bone-marrow-containing monocytemacrophage precursors) might be in antigen processing or in increased availability for effector function (specific or nonspecific), or both. In effect, a considerable body of evidence shows that the immune defect in neonates can be repaired by adult macrophages or their precursors (Argyris, 1968; Blaese, 1975 The increased frequency of tumours observed in the newborn recipients after the transfer of low numbers of spleen, neutrophils or thymus cells may be the result of a mechanism of tumour immunostimulation as proposed by Prehn (1972) , Prehn and Lappe (1971) . An apparently similar block or enhancement exerted by different cell numbers has been reported in several systems, both in vitro (Prehn, 1972; Klein, 1972; Fidler, 1973; Fidler, Brodey and Bech-Nielsen, 1974; Kall and Hellstrom, 1975; Nathan and Terry, 1975) and in vivo (Belayev and Gruntenko, 1972; Fidler, 1974; Carnaud et al., 1974; Umiel and Trainin, 1974) . However, in the present case, the effect of the transferred leucocyte populations may not be merely the result of direct interaction of leucocytes on tumour cells, since the inoculation of leucocytes was made 24 h prior to tumour inoculation and by a different route from the neoplastic cells. In effect, while the immunocapability of the recipient neonatal mice appears very poor (Adler, Takiguchi and Smith, 1971) it is possible that the transferred leucocytes primarily act by modulating in different ways the immunological reactivity of the recipients.
In this case, different numbers of the various leucocyte populations transferred may enhance or overcome the host T-cell suppressor activity which seems to play a dominant role in determining the immune reactivity of the newborn mice (Mosier and Johnson, 1975) . In this regard, several recent studies have emphasized the role of different suppressor cells in the inhibition of the cytotoxic response to tumour-associated antigens (Kirchner et al., 1974; Gershon, Birnbaum Mokyr and Mitchell, 1974) .
Alternatively, various ratios of transferred leucocyte populations may selectively promote the production ofenhancing serum factors. However, previous studies from this laboratory showed that soluble serum factors seem not to play a determinant role in enhancing MOPC-460 growth in syngeneic adult hosts (Forni and Comoglio, 1974) .
It might also be possible that the administration to neonates of many viable leucocytes brings into play homoeostatic mechanisms which suppress the activity of leucopoietic stem cells in general and malignant plasmablasts in particular. However, comparable experiments with non-lymphoid tumours such as a syngeneic sarcoma and a mammary adenocarcinoma (both spontaneous), showed that similar patterns of blocking and enhancement can be obtained in tumours of different histology and aetiology, while different leucocyte numbers were required to reproduce the biphasic activity (Forni and Giovarelli, in preparation) .
At present, the mechanisms by which the various cellular interactions block or enhance MOPC-460 growth in the newborn recipients is not clear. Further analysis is required, both in vivo and in vitro, using highly purified cellular populations, to understand how the different leucocytes modify specifically or not the immunocapability of newborn mice. In any case, our results show that, on transferring increasing amounts of some leucocyte populations from normal donors into neonatal recipients, a critical level is reached, below which there is a marked stimulation, and above which there is a block of tumour growth.
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